Principal component analysis of RNA‐seq data showed a trend toward grouping of all the subacute data regardless of atorvastatin treatment (pretreatment versus subacute [Figure S6 ]).
← all excerpts
RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease.
1
—
—